II. Epidemiology
- As many as 30% of over age 50 years old complain of dry, irritated eyes
III. Causes
- Sjogren's Syndrome
- Allergic Conjunctivitis
- Blepharitis
- Decreased blinking with prolonged reading or driving
- Chronic exposure to dry, dusty conditions
- Rosacea
- See Medication Causes of Dry Eyes (e.g. Anticholinergic Medications, Diuretics, Estrogen Replacement)
IV. Management
-
General measures
- Sunglasses
- Room humidifiers
- Tobacco Cessation
- Take computer breaks
- Protect eyes from fan
- Avoid drying, Anticholinergic Agents (Antihistamines, Tricyclic Antidepressants, Diuretics)
- Use 20-20-20 rule
- Shift eye focus every 20 min to something 20 feet away for 20 seconds
- Artificial tears or ointments
- Preservative-free solutions are preferred (e.g. Refresh Plus), esp. if used more than 4x/day
- Contact Lens users may try rewetting drops (e.g. Renu rewetting, Blink Contacts)
- Consider eye lubricants (e.g. lacrilube) for moderate symptoms (esp. at night), but may blur Vision
- Avoid agents with Decongestant (e.g. Visine original)
- Consider Muscarinic Agonists and other agents in Sjogren's Syndrome refractory to other measures
- Cyclosporine twice daily (expensive, at $500/month)
- Remove contacts before instilling drops (and wait 15 min before reinserting)
- Restasis 0.05% emulsion (preferred over Ceqo)
- Cequa 0.09% solution
- Pilocarpine (Salagen)
- Cevimeline (Evoxac)
- Cyclosporine twice daily (expensive, at $500/month)
- Other options in refractory cases
- Lifitegrast (Xiidra)
- Lymphocyte function-associated Antigen-1 (LFA-1) Antagonist ophthalmic solution
- One drop instilled every 12 hours
- Expensive (>$400/month), with risk of eye irritation, altered Taste Sensation
- Contact Lenses must be out of eye for installation for at least 15 minutes after administration
- Ophthalmic Corticosteroid
- Short-term use only (<2 weeks) for severe Dry Eye flare
- Consider consult with ophthalmology
- Risk of Glaucoma, Cataracts and infection
- Eysuvis (loteprednol) 0.25% suspension is FDA approved for Dry Eyes (but costs nearly $500 per course)
- Dexamethasone 0.1% ophthalmic solution is <10% of Eysuvis cost and is used off-label for Dry Eyes
- Intranasal Varenicline (Tyrvaya)
- Varenicline 0.03 mg used intranasally ($600/month in 2021)
- Results in Cholinergic effects to increase tear production (may have a modest effect)
- Minimal systemic absorption (8%)
- Varenicline used systemically is Chantix
- References
- (2021) Presc Lett 28(12): 70
- Lifitegrast (Xiidra)
- Avoid measures that are unlikely to be helpful
- HydroEye (Omega-3 Fatty Acid) has no quality studies demonstrating efficacy
V. Diagnosis
- See Schirmer's Test
VI. References
- (2021) Presc Lett 28(1): 6
- (2019) Presc Lett 26(5)
- (2016) Presc Lett 23(9)
- (2015) Presc Lett 22(1): 5
- Ono (2004) Am J Ophthalmol 138(1): 6-17 [PubMed]
- Whitcher (2004) Br J Ophthalmol 88(5): 603-4 [PubMed]